Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;11(2):345-352.
doi: 10.1007/s13346-021-00929-2. Epub 2021 Feb 13.

Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems

Egor Egorov #  1 , Calvin Pieters #  1 , Hila Korach-Rechtman  1 , Jeny Shklover  1 , Avi Schroeder  2
Affiliations

Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems

Egor Egorov et al. Drug Deliv Transl Res. 2021 Apr.

Abstract

The field of nanotechnology and personalised medicine is undergoing drastic changes in the approach and efficiency of experimentation. The COVID-19 pandemic has spiralled into mass stagnation of major laboratories around the globe and led to increased investment into remote systems for nanoparticle experiments. A significant number of laboratories now operate using automated systems; however, the extension to nanoparticle preparation and artificial intelligence-dependent databases holds great translational promise. The strive to combine automation with artificial intelligence (AI) grants the ability to optimise targeted therapeutic nanoparticles for unique cell types and patients. In this perspective, the current and future trends of automated approaches to nanomedicine synthesis are discussed and compared with traditional methods.

Keywords: Artificial intelligence; Automation; Microfluidics; Nanotechnology; Personalised medicine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic diagram of an AI-automated workstation. A functional AI-guided robotic nanoparticle synthesis and analysis system will start with genetic analysis of individual patients and personalised treatment selection. The nanoparticle will then be formulated and tested in cells and organs-on-chip using automated systems. The AI system will ultimately be able to determine the best formulation and treatment for individual patients for maximum response and optimal outcome
Fig. 2
Fig. 2
In the field of pathology, AI is already making major changes. Similar impact of AI can occur in the field of nanomedicine synthesis and prediction. Graphical representation of PubMed results based on two search queries—[“Machine Learning” AND “Laboratory Medicine” and “Machine Learning” AND “Pathology”]
Fig. 3
Fig. 3
Graphical comparison of the hands-on and automated approaches to experimentation
See this image and copyright information in PMC

References

    1. Unesco. 1.3 billion learners are still affected by school or university closures, as educational institutions start reopening around the world, says UNESCO. UNESCO. 2020.
    1. Commission FT: securing remote access to your network. https://www.ftc.gov/tips-advice/business-center/small-businesses/cyberse... (2019). Accessed 23 Jan 2021.
    1. Hrkach J, Langer R. From micro to nano: evolution and impact of drug delivery in treating disease. Drug Deliv Transl Res. 2020;10(3):567–570. doi: 10.1007/s13346-020-00769-6. - DOI - PMC - PubMed
    1. Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. Pharmacol Ther. 2017;42(12):742–755. - PMC - PubMed
    1. Mg K, Krenn V, F H. History and possible uses of nanomedicine based on nanoparticles and nanotechnological progress. J Nanosci Nanotechnol. 2015;06. 10.4172/2157-7439.1000336.

Publication types